Living with glaucoma often means a lifetime commitment to daily eye drops to manage intraocular pressure and preserve vision. However, developments from Glaukos Corporation signal a promising shift in treatment. The company's innovative iDose TR implant showed highly positive outcomes in its Phase 3 clinical trials, offering new hope for patients seeking an alternative to daily medications. A Game-Changer in [...]